Manufactures hydrogels for wound care and transdermal drug delivery.
Jun 2026Revenue $12.1M/yrExpenses $17.5M/yr
No trend
Figures by year
When will Nexgel be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $12.1M and expenses $17.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $11.4M | $14.8M | −$3.35M |
| Dec 2024 | $8.69M | $12.2M | −$3.55M |
| Dec 2023 | $4.09M | $7.57M | −$3.48M |
| Dec 2022 | $2.05M | $5.40M | −$3.35M |
| Dec 2021 | $1.55M | $4.12M | −$2.57M |
| Dec 2020 | $674K | $2.93M | −$2.26M |
| Dec 2019 | $717K | $2.64M | −$1.92M |
| Dec 2018 | $2.21M | $4.10M | −$1.89M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.